EuroHeart
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EuroHeart

 

Where Data Shapes the Future of Heart Care 

 

The mission of EuroHeart is to improve cardiovascular care by monitoring high-quality harmonised patient data at hospital admission and over time. This approach can provide healthcare professionals with real-time insights, advancing the standard of care and driving better patient outcomes.
 

EuroHeart has released its latest annual report, presenting 2024 data, this report marks a major milestone in EuroHeart's mission to advance cardiovascular care by offering deeper medical insights and highlighting critical areas for improvement across Europe. 

The report emphasizes a systematic approach that considers age, gender, and diabetes, ensuring more personalized care. Access to detailed data supports evidence-based clinical decisions and allows healthcare systems to learn from each other's strengths and weaknesses.

EuroHeart remains committed to enhancing cardiovascular care through data-driven insights and international collaboration.

Read the report


 

 

euroheart-logo.jpgEuroHeart is an ESC initiative based on a collaboration between national registries and in collaboration with national cardiac societies. The aim of national registries is to continually monitor quality of care at national and local levels as a necessary prerequisite to improving care effectively. EuroHeart is predominantly designed for the benefit of patients, citizens and the planning of healthcare investments.

The EuroHeart initiative

The EuroHeart Initiative, led by the European Society of Cardiology (ESC), aims to improve cardiovascular care by fostering international collaboration and supporting high-quality data collection across healthcare systems.

Our Journey So Far:

  • Pilot Phase (2019–2021):
    In July 2019, the ESC Board approved the launch of a two-year pilot phase across two to four countries to assess the feasibility of implementing EuroHeart in diverse healthcare systems.
  • Consolidation Phase (2022–2024):
    Following the successful pilot, the ESC Board approved the consolidation phase in October 2022. This phase focused on maintaining and expanding the network of collaborating countries and concluded in December 2024.

What’s Next (From 2025 Onwards):

With the successful completion of the Pilot and Consolidation Phases, the EuroHeart Initiative is now entering its next chapter. This new phase will focus on:

  • Maintaining and Enhancing the EuroHeart Registry IT Platform: Ensuring the platform continues to evolve to meet the initiative’s growing needs.
  • Expanding ESC-Generated Observational Data: Increasing the scope of data collection to drive new insights in cardiovascular care.
  • Advancing the Registry Programme:
    • Supporting direct quality development to improve patient outcomes.
    • Enabling device monitoring to ensure safety and efficacy.
    • Facilitating registry-based randomised trials to advance clinical research.
  • Strengthening the EuroHeart Network: Increasing participation from more countries and healthcare institutions.
  • Ensuring Data Quality and Completeness: Maintaining the highest standards for reliable and comprehensive data.
  • Developing and Maintaining Data Standards: Establishing consistent frameworks to standardise data collection and reporting.
  • Enabling Advanced Data Analysis: Leveraging cutting-edge analytical tools to extract actionable insights.

The EuroHeart Initiative remains dedicated to shaping the future of cardiovascular care through innovation, collaboration, and data-driven excellence.

Key features

Collaborative National Programmes:
Built on partnerships between national programmes using common data sets, standardized methodologies, and shared quality criteria.

Inclusive Governance:
Involves representatives from participating countries in the development process and all subcommittees.

Continuous Quality Improvement:
Enhances care quality through the ongoing collection and analysis of patient data for real-time improvements.

Standardised Data Sets and Quality Indicators:
Expands standardised data sets and quality indicators across key cardiovascular areas:

  • ACS-PCI
  • Heart Failure
  • Atrial Fibrillation
  • Valve Disease

Advanced Data Science Center:
Develops a Data Science Center to support collaborative research and advanced analytics in partnership with national registries.

Enhanced Registry IT Platform:
Offers an optional IT platform to support:

    • Device surveillance
    • Registry-based randomized clinical trials (R-RCT)
    • Flexible data integration

EuroHeart Executive Committee

Chair: Prof. Lars Wallentin

Deputy Chair: Prof. Eva Prescott

Members: Prof. Barbara Casadei, Prof. David Erlinge, Prof. Rajesh Kharabanda, Prof. Stefan James, Sara Hansson

ESC Representative: Aline Abravanel, Valentina Tursini

Operational Lead; Project manager: Adham Gharieb

Senior Advisor; Project manager: Ebba Bergman

Contact

For more details about the EuroHeart project, Data standards, EuroHeart Registry IT platform and its development, or if you would like your country to participate in the EuroHeart project, please contact us by email.